Armata Pharmaceuticals, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Armata Pharmaceuticals, Inc. Common Stock (ARMP) has a 3-month relative strength percentile of 16 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 73. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 10.0%, relative volume 15.77×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
16 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
ARMP is held by 2 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $2M notional.
Top 2 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $2M |
| VXFVanguard Extended Market ETF | 0.00% | $1M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ARMP Jan avg: 43.02% median: 12.54% win: 100% σ: 65.03% n: 4 2022-04-12 → 2026-05-29 | ARMP Feb avg: 12.85% median: 1.61% win: 50% σ: 32.57% n: 4 2022-04-12 → 2026-05-29 | ARMP Mar avg: -15.30% median: -15.65% win: 25% σ: 19.33% n: 4 2022-04-12 → 2026-05-29 | ARMP Apr avg: -9.06% median: -2.99% win: 20% σ: 18.02% n: 5 2022-04-12 → 2026-05-29 | ARMP May avg: -3.82% median: -12.98% win: 40% σ: 17.89% n: 5 2022-04-12 → 2026-05-29 | ARMP Jun avg: -4.88% median: -2.85% win: 25% σ: 6.96% n: 4 2022-04-12 → 2026-05-29 (current) | ARMP Jul avg: 38.87% median: 17.43% win: 100% σ: 54.34% n: 4 2022-04-12 → 2026-05-29 | ARMP Aug avg: 6.50% median: -0.07% win: 50% σ: 22.52% n: 4 2022-04-12 → 2026-05-29 | ARMP Sep avg: 1.84% median: 0.73% win: 50% σ: 13.72% n: 4 2022-04-12 → 2026-05-29 | ARMP Oct avg: 1.61% median: -13.77% win: 25% σ: 43.84% n: 4 2022-04-12 → 2026-05-29 | ARMP Nov avg: 3.76% median: -1.55% win: 25% σ: 33.42% n: 4 2022-04-12 → 2026-05-29 | ARMP Dec avg: -6.06% median: -16.95% win: 25% σ: 37.45% n: 4 2022-04-12 → 2026-05-29 |